chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red raised well demarcated area to rigth deltoid, non-tender; extremely itchy. Localized to injection site, 8 days post  vaccine. Some mild soreness to right axilla and right anterior cervical area. Rash is continuing to spread across upper arm, began as a half dollar sized, raised welt and is now approx 7 inches long by 4 inches wide, wrapped around arm.
35-year-old female with past medical history of uterine fibroids, hypertension, syncopal episodes.  She presents the emergency department after a witnessed syncopal episode at a vaccine clinic. She states she has had a syncopal episodes in the past which involved her being on her menstrual cycle and experiencing very painful menstrual cramps. She states this was no different in the past and she states she is currently on her cycle and was having extreme pain which she describes menstrual cramps before her syncopal episode. Her mother witnessed the syncopal episode and states she did not fall there is no signs of trauma on the patient. Patient states she would not come to emergency room other than staff at the vaccine site urging her to come. After using the Wells criteria on the patient it exhibits a very low risk approximately 2% that the patient has a pulmonary embolism. She had tachycardia upon arrival with a rate of 105, But she is currently having multiple pulse checks that have all been under 100 bpm.Patient was given fluids and lab work was ordered.  Patient to be discharged, on physical exam and evaluation of lab work there is no concern for pulmonary embolism or any emergent condition.
Rash, Hives, Diahrea, vomiting, Low Blood pressure, flu like symtoms, fatigue weakness, Dizziness, no energy. Blood work numbers way off normal. Slept for days. Total exhaustion. Chills
itchiness throughout my body; its frustating; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness throughout my body) and IRRITABILITY (its frustating) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchiness throughout my body) and IRRITABILITY (its frustating). At the time of the report, PRURITUS (itchiness throughout my body) and IRRITABILITY (its frustating) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medication was reported.
3/18/21 severe stomach pain. 3/19/21 stomach sore and firm
No additional AE reported; Customer called for a temperature excursion and reported PROQUAD that had undergone temperature excursion was administered to patients before calling. No additional AE reported. No PQC reported. No patient demographics was provided. No further i; This spontaneous report has been received from a medical assistant, regarding a 4-years-old female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 10-DEC-2022, a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) underwent a temperature excursion between 6- and 14-degrees Fahrenheit (F) for one hour, this as a result of data logger. On 15-DEC-2022, the patient was vaccinated with the improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) subcutaneous injection, intramuscularly in the right thigh as prophylaxis (lot number: W019628, which was determined to be valid, with an expiration date on 19-DEC-2023) (strength, dose and scheme were not reported). There was not any report on previous temperature excursion.   This case is one of multiple reports from the same reporter.; Sender's Comments:  US-009507513-2304USA007822: US-009507513-2304USA007836: US-009507513-2304USA007837: US-009507513-2304USA007843: US-009507513-2304USA007869:
Pt bled and developed 1 inch knot w/ 1 cm bruise after DTaP in (R) upper thigh.
Reaction started at 9pm with initial fatigue by 11 pm experienced chills, sweats, restlessness, muscle twitching in abdomen and pelvis, sharp stabbing pain in left mastoid, swelling under left scilla and neck, fever TMAX 102, lasted until 0548 am 01/26/2021. Fever chills and muscle spasm have resolved. Stabbing pain in mastoid lasted until evening 01/26/2021. Continued left axillary swelling and neck swelling. Treated with Motrin Tylenol hydration and rest.
Wakefulness, mild nausea, mild diarrhea, overall achiness, chills, shivering, fever.
Information has been received from a physician concerning a 24 year old female patient with no pertinent medical history who on 08-APR-2011, was vaccinated with the first dose of GARDASIL 0.5 ml, IM (lot number 667866/1437Z, Exp. 25-FEB-2013). Concomitant therapy included doxycycline and OCELLA. On 08-APR-2011, the patient experienced injection site redness and swelling. Both arms from elbows to hands were covered with a pimply itchy rash. The patient did not seek medical attention. The patient did not receive any treatment for the event. Therapy with GARDASIL was discontinued and no reintroduced. At the time of the report the patient still had symptoms. Additional information has been requested.
pt recvd vax; on 19oct95 devel a discrete, gen macular papular rash; subsequently recovered
Right Deltoid redness, increased warmth, edema 3 inches x 3 inches, complains of itching at site.
pt looked a bit disoriented after administration and then fainted.  after asking if okay a couple times, she came to, and said she was okay.   We had her lie down on the floor and she said that made her feel better.  She said she had a buzzing sound in her ears and that decreased with time.  She said that is a normal symptom of when she is having a panic attack.
Client received 2nd Varicella shot and Tdap shot. 2 minutes after Tdap client had rigid stiffening of body lasting 30 seconds followed by diaphoresis, nausea, pallor, and feeling faint. No rash or breathing/swallowing difficulty.
Pink circular rash approximately 1 inch in diameter started 6 days after injection at the injection site. The next day (7 days after injection)  the rash was itchy and larger, approximately 1.5-2in in diameter. The next day, today, (8 days after injection) the rash developed a dark red circle around the outside of the original pink rash.
Patient is a 19-year-old female with no significant past medical history BIBself with report of midsternal chest pain (described as soreness) that started around 8:20 AM when she woke up with associated jaw pain and L>R upper extremity pain. She reports pain is worse with deep breaths and has improved significantly since it started (currently rated 2/10). She took three ibuprofen tabs (presumably a total of 600 mg) prior to presentation but took no other pain medications. Denies abdominal pain, nausea, vomiting, fever, chills, leg pain or swelling. Denies cigarette, alcohol, or drug use. Patient received her 2nd Pfizer COVID vaccine 4 days ago, with initial side effects of chills, body aches, and intermittent headaches resolving yesterday. Emergency Department to Inpatient.
felt cold like; achy; This is a spontaneous report from a contactable consumer (patient).  A 75-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unknown route of administration on 16Feb2021 (lot number: EL9264, expiration date: 31May2021) (age at vaccination 75-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history included shoulder surgery on an unknown date and physical therapy included cortisone shot. The patient concomitant medications were not reported as none. The patient had felt cold like and achy on 17Feb2021. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.
I am the epidemiologist reporting on behalf of patient.  Case was admitted after daughter found Dad on the floor was previously being treated for a UTI -- Transported to the ED as he had Difficulty breathing -- during hospital start was treated for COVID Pneumonia -- was treatment at hospital and discharged 8/6 -- 8/7 Returned to ED w/Acute Respiratory Distress -- Daughter was by bedside declined Mechanical Inc -- pt. expired 3 hrs later. Patient was fully vaccinated with Pfizer on 2/17 and 3/10.
Lightheaded/dizzy; Spotty/cloudy vision; Tongue tingling; Hand tingling; Low grade fever; Headache that moved from forehead to behind left eye; Headache that moved from forehead to behind left eye; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Mar2021 at 09:30 (at the age of 20-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 14:30, the patient experienced face/tongue/hand tingling, low grade fever (reduced with Tylenol), lightheaded/dizzy, spotty/cloudy vision, headache that moved from forehead to behind left eye. On 08Apr2021, the patient underwent nasal swab test for COVID-19 and the result was pending. Therapeutic measures were taken as a result of the event low grade fever which included treatment with TYLENOL. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events face/tongue/hand tingling, low grade fever, lightheaded/dizzy, spotty/cloudy vision, headache that moved from forehead to behind left eye was recovering at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
I had nothing but a cough. It lasted quite awhile. At least a few months. I didn't take any medication for the cough. It was just bothersome but nothing too serious.
Fever for 24 hours as high as 104.0 with pounding headache, shaking chills, severe muscle aching and having to rest in bed.
8-16-13 Vaccine administered at 2:30pm. 8-17-13 Patient seen in pharmacy presenting 2" welt, warmth and pain at injection site. Told to take BENADRYL and TYLENOL and use cool compresses at 4pm. 8-18-13 Patient presented with 2 welts on left arm, each about 3" in diameter with complaints of warmth and pain. Patient was sent to Urgent Care facility by pharmacist at 4pm. Patient received a SOLU-MEDROL injection at 4:30pm. 8-19-13 Patient was seen again at Urgent Care for another shot of SOLU-MEDROL and was given a prescription for prednisone 10 mg. Dr. at Urgent Care reported improvement at that time.
leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine; leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine; leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of MUSCLE SPASMS (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine), PAIN (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine) and CONDITION AGGRAVATED (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine) in a 56-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 024H22A) for COVID-19 prophylaxis.     Concurrent medical conditions included Cramps leg and Pain.    On 29-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 30-Dec-2022, the patient experienced MUSCLE SPASMS (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine) and PAIN (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine). On an unknown date, the patient experienced CONDITION AGGRAVATED (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine). At the time of the report, MUSCLE SPASMS (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine) and PAIN (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine) was resolving and CONDITION AGGRAVATED (leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. patient reports having leg cramping and pain issues before receiving the Moderna Bivalent vaccine and symptoms worsening a day after receiving the vaccine It was unknown if the patient experienced any additional symptoms or events. Medication Details and reason for taking the medicine. No treatment medications were reported.   Reporter did not allow further contact
This spontaneous report as received from a registered nurse refers to a 6 month (also reported as 7 month) old female patient. No concurrent condition or medical history reported. On 21-APR-2015 at 10:30 hours, the patient was vaccinated with third dose of RECOMBIVAX HB, (Lot# L001456) intramuscular (RVL) which was exposed to temperatures outside of the recommended range. On the same day, the refrigeration temperature was out of range for 30 minute (-1.8 degree Celsius). It was advised that the vaccine was not stable, patient was called to be revaccinated. The patient was vaccinated at private doctor's office and the vaccine was purchased with private funds. Additional information has been requested.
Swelling, pain, redness, induration involving the entire left upper arm; associated with flu-like symptoms. Prolonged course-poorly responsive to antihistimines or antibiotics. Admitted to hospital 4/30/00. Follow-up reports that the pt still has a hard knot on the arm in the area of vax and also complained of fatigue. Per F/U; the pt was seen by the physician on 4/13/00 because of a left thumb crushing injury. He was administered Tetanus Toxoid. He was dx'd on 4/19/00 with cellulitis and administered IM ceftriaxone sodium for 2 days, then prescribed oral amoxicillin/clavulanate for 7 days. He later received IM ceftriaxone sodium for the next 3 days. The next day, the physician performed a needle aspiration to decompress the area because it was firm approx. the size of a 50 cent piece. His physician prescribed cefazolin for 3 days to be given at an infusion facility. The pt was depressed. At the infusion facility, the pt indicated that he had lost 7 pounds, had no appetite and experienced diarrhea for the past 2 weeks. On 4/30/00, his arm infection worsened; he developed streaking. He was admitted to the hospital for IV antibiotics with a dx of "Type III hypersensitivity", "arthur" reaction, "serum sickness", left arm pain and possible abscess, cellulitis and lymphangitis. He was treated also with rocecoxib. Then Citalopram was prescribed. Methylprednisolone sodium succinate was prescribed and the pt was discharged from the hospital with an additional prescrition for rabeprasole. He was prescribed propoxyphene napaylate for pain on 5/5/00. On 5/10/00, the MD noted that the pt experienced a red face, palpitations, hand shaking and urinary hesitancy with dribbling. Nitrofurantoin was prescribed and his dosage of prednisone was decreased. This did not help. Tamsulosin hydrochloride was prescribed on 5/17/00. The pt continued to have urinary frequency, hesitancy, difficulty urinating, tremors and sleeplessness. On exam, the fibrous thickened area at the injection site on his left arm had improved. Flomax was discontinued; prednisone tapering was initiated. As of 5/16/01, the pt had recovered.
This spontaneous report was received from a consumer and refers to an unspecified number of female patients of unknown ages. No medical history or concurrent conditions were reported. On unknown dates, the patients were vaccinated with doses of GARDASIL (dose, dosage number, route of administration, anatomical location, lot # and expiration date were not reported). No concomitant medications were reported. Subsequently, on unknown dates, the patients suffered adverse effects. The outcome of these adverse effects were unknown. The reporter considered adverse effects to be related to the vaccination with GARDASIL This is one of the several reports received from the same reporter Additional information has been requested.
DATE OF INJECTION, PAIN, SORENESS OF LEFT ARM STARTED WITHIN 2 HRS.  NEXT DAY, HEADACHE, 4" CIRCLE OF REDNESS  AND SWOLLEN AROUND INJECTION SITE, FEVER OF 99.7, CHILLS.    SECOND DAY, HEADACHE, FEVER OF 101.1, ACHY, CHILLS, TIRED, CIRCLE OF REDNESS  AND SWOLLEN PAINFUL  AREA AROUND INJECTION SITE SPREADING, LEFT ARMPIT SORE.   THIRD DAY, ONLY ABOUT 6" LONG BY 5" WIDE REDNESS/SWELLING/TENDERNESS AROUND INJECTION SITE REMAINS.
Dizziness; Weakness; Swollen lymph nodes; Barely walk; Fatigue; Larger patch of hives; Arm pain; large hives as well as small patches of hives; Chills; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Feb-2021 and was forwarded to Moderna on 27-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ANGIOEDEMA (Larger patch of hives) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ANGIOEDEMA (Larger patch of hives) (seriousness criterion medically significant), PAIN IN EXTREMITY (Arm pain), URTICARIA (large hives as well as small patches of hives) and CHILLS (Chills). On 27-Feb-2021, the patient experienced GAIT INABILITY (Barely walk), DIZZINESS (Dizziness), ASTHENIA (Weakness), LYMPHADENOPATHY (Swollen lymph nodes) and FATIGUE (Fatigue). At the time of the report, ANGIOEDEMA (Larger patch of hives), GAIT INABILITY (Barely walk), PAIN IN EXTREMITY (Arm pain), URTICARIA (large hives as well as small patches of hives), DIZZINESS (Dizziness), ASTHENIA (Weakness), LYMPHADENOPATHY (Swollen lymph nodes), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.  This case concerns a 78 Y/O M with a serious unexpected event of angioedema and non-serious unexpected dizziness, asthenia, pain in extremity, gait disturbance, and expected chills, fatigue, lymphadenopathy.  Event onset the same day as first dose mRNA-1273. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a 78 Y/O M with a serious unexpected event of angioedema and nonserious unexpected dizziness, asthenia, pain in extremity, gait disturbance, and expected chills, fatigue, lymphadenopathy.  Event onset the same day as first dose mRNA-1273. Event outcome unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Received expired vaccine on 05Jan2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired vaccine on 05Jan2022) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 ml. On 05-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired vaccine on 05Jan2022). On 05-Jan-2022, EXPIRED PRODUCT ADMINISTERED (Received expired vaccine on 05Jan2022) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information was provided. No treatment medication were provided. The vaccine was open at 8:17 AM on 04Jan2022 and needed to be discarded at 8:17 PM on 04Jan2022. No adverse event reported to the facility.
Patient had spots that started small and turned into big red blotches (started 8/22/10) and were itchy. Started on face and went down torso. Went to doctor and was put on steroid cream.
After 6 days developed itching and redness around injection area. A bit of soreness.
The pharmacy gave me the booster first when I was only there to get my first vaccine. Then they gave me the normal vaccine after that. Two shots in 15 minutes. I have been bedridden with high fever, dizziness and shakes ever since.
24 hrs, post immun, 1 of 4  pt's exp h/a, swelling & pain @ inject site, inability to move arm, fever of 101-103, & a cough for 3 days; tx APAP for pain & fever;
chills, slight fever, body aches, vomiting, rash near injection site.treatment: tylenol/advil for discomfort.
Tingling in throat @ 20 minutes after shot. Then lips felt very tingly but not swollen. Then my entire body (different parts) itched on and off for two days. I contacted my primary doctor who had me take zyrtec to alleviate the itch. Walgreens staff DID NOT make anyone stay for 15 minutes after their shots to make sure there were no reactions. They are also NOT giving the second dose until FOUR WEEKS LATER not the recommended THREE.  I wish I had known this before I went there - there are so many other facilities that are doing a wonderful job.
On 4/10/21 around 2:30 pm I gave the patient his first Moderna COVID vaccine and had him sit in the observation area for the standard 15 minutes. Around 2:35 he and his family notified me that he was feeling lightheaded/faint and nauseous; he also appeared pale and diaphoretic. It seemed to be a vasovagal reaction until he said he was starting to have trouble breathing so I called 911 and got the Epipen/emergency kit ready, and monitored vitals. Then his breathing trouble resolved without needing to administer medication. EMS arrived at 2:39 pm and confirmed his HR/BP/O2 sat were normal. EMS cleared the patient to go home with his family. The patient had never had a vaccine reaction or vasovagal reaction before.